Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Vemurafenib and BRAF inhibition: a new class of treatment for metastatic melanoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vemurafenib and BRAF inhibition: a new class of treatment for metastatic melanoma.
Vemurafenib and BRAF inhibition: a new class of treatment for metastatic melanoma. Clin Cancer Res. 2012 Jan 01; 18(1):9-14.
View in:
PubMed
subject areas
Animals
Humans
Indoles
Melanoma
Proto-Oncogene Proteins B-raf
Sulfonamides